C

CER Instituto Medico | Buenos Aires, Argentina

Research site
(Unclaimed)
Location
Vicente Lopez Street 1441, Quilmes, Buenos Aires, Argentina
Site insights

Top conditions

Ulcer (5 trials)

Ulcerative Colitis (5 trials)

Colitis (5 trials)

Systemic Lupus Erythematosus (5 trials)

Arthritis (3 trials)

Top treatments

Mirikizumab
Upadacitinib
Baricitinib
Ixekizumab
Taxane
Adalimumab
Platinum
Farletuzumab
Carboplatin
Efavaleukin Alfa

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

6 of 16
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed as clinical resp...

Active, not recruiting
Ulcerative Colitis
Drug: Placebo SC
Drug: Mirikizumab SC

This study is designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative col...

Enrolling
Ulcerative Colitis
Drug: Mirikizumab

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis...

Active, not recruiting
Ulcerative Colitis
Drug: Mirikizumab
Drug: Placebo

The primary objective of this study is to evaluate the long-term safety and tolerability of efavaleukin alfa in participants with moderate to severe...

Enrolling
Ulcerative Colitis
Drug: Efavaleukin alfa
Drug: Placebo

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how s...

Enrolling
Systemic Lupus Erythematosus
Drug: Upadacitinib
Drug: Placebo

The main purpose of this study is to evaluate the effect of efavaleukin alfa on induction of clinical remission in participants with moderately to se...

Enrolling
Ulcerative Colitis
Drug: Placebo
Drug: Efavaleukin alfa

Trial sponsors

Lilly logo

Lilly (8 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems